EMEA-000347-PIP02-16

Key facts

Active substance
Bilastine
Therapeutic area
Ophthalmology
Decision number
P/0009/2019
PIP number
EMEA-000347-PIP02-16
Pharmaceutical form(s)
Eye drops, solution
Condition(s) / indication(s)
Treatment of allergic conjunctivitis
Route(s) of administration
Ocular use
Contact for public enquiries
Faes Farma S.A.

Tel.  + 34 94818300

E-mail: bsantos@faes.esieguidazu@faes.es

Decision type
P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s)

Decision

How useful was this page?

Add your rating